Conflicts of Interest
RRB
JSD has received grant/research support from Allergan, Cutera, Cynosure, Bausch and Lomb, Syneron Candela, Lumenis, Revance Therapeutics, Inc., Zeltiq, Evolus, and L’Oréal; has received use of equipment from Cutera, Cynosure/Hologic, Lumenis, Candela/Syneron, and Allergan/Zeltiq; has equity ownership/stock options in Follica and Vyome, and has served as a consultant and/or on the advisory boards of Allergan, Cynosure, Cutera, Follica, Zeltiq, Bausch and Lomb, Revance Therapeutics, Inc., Vyome; Follica, L’Oréal, and Soliton. SH is a speaker, consultant, and/or investigator for Allergan, Evolus, Galderma, Medytox, Merz, and Revance Therapeutics. RRB is an owner and employee of B2S Life Sciences. AC is an employee of B2S Life Sciences. CJG is an employee of, and holds stock/stock options in Revance Therapeutics, Inc. YL and GP were employees of Revance Therapeutics, Inc. during the conduct of the study. 